SYNLOGIC, INC. Proceeds from Issuance of Preferred Limited Partners Units
SYNLOGIC, INC. (SYBX) reported Proceeds from Issuance of Preferred Limited Partners Units of $26.65 million for the 12-month period ending 2017-12-31, per its 10-K filed 2019-03-12.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfPreferredLimitedPartnersUnits · last filed 2019-03-12
- SYNLOGIC, INC. proceeds from issuance of preferred limited partners units for the quarter ending 2017-12-31 was $0.00.
- SYNLOGIC, INC. proceeds from issuance of preferred limited partners units for the quarter ending 2017-09-30 was -$1.00K.
- SYNLOGIC, INC. proceeds from issuance of preferred limited partners units for the quarter ending 2017-06-30 was $0.00.
- SYNLOGIC, INC. proceeds from issuance of preferred limited partners units for the quarter ending 2017-03-31 was $26.65M.
- SYNLOGIC, INC. proceeds from issuance of preferred limited partners units for fiscal 2017 was $26.65M, a 13.28% decline from fiscal 2016.
- SYNLOGIC, INC. proceeds from issuance of preferred limited partners units for fiscal 2016 was $30.73M.
| Period end | Proceeds from Issuance of Preferred Limited Partners Units 3 month | Proceeds from Issuance of Preferred Limited Partners Units 6 month | Proceeds from Issuance of Preferred Limited Partners Units 9 month | Proceeds from Issuance of Preferred Limited Partners Units 12 month |
|---|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | -$1.00K derived: sum of 2 quarters · filed 2019-03-12 | -$1.00K derived: sum of 3 quarters · filed 2019-03-12 | $26.65M 10-K · filed 2019-03-12 |
| 2017-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | -$1.00K derived: sum of 2 quarters · filed 2018-11-13 | $26.65M 10-Q · filed 2018-11-13 | $26.44M derived: sum of 4 quarters · filed 2018-11-13 |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $26.65M 10-Q · filed 2018-08-09 | $26.44M derived: sum of 3 quarters · filed 2018-08-09 | |
| 2017-03-31 | $26.65M 10-Q · filed 2018-05-15 | $26.44M derived: sum of 2 quarters · filed 2018-05-15 | ||
| 2016-12-31 | -$210.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-20 | $30.73M 10-K · filed 2018-03-20 | ||
| 2016-09-30 | $30.94M 10-Q · filed 2017-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |